HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT (Q28294446)

https://api.crossref.org/works/10.3109/13697137.2013.808563

Effects of bazedoxifene alone and with conjugated equine estrogens on coronary and peripheral artery atherosclerosis in postmenopausal monkeys

21 April 2017

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Micronized progesterone and its impact on the endometrium and breast vs. progestogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

The cost-effectiveness of hormone therapy in younger and older postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54-65

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Duration of menopausal hot flushes and associated risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Endometrial cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Hormone therapy and risk of myocardial infarction: a national register study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Effects of short-term transdermal hormone replacement therapy on glycaemic control, lipid metabolism, C-reactive protein and proteinuria in postmenopausal women with type 2 diabetes or hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Hot flashes are associated with increased ambulatory systolic blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Premature menopause or early menopause and risk of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Association between hormone replacement therapy and subsequent stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Progestogens and venous thromboembolism among postmenopausal women using hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Hormone therapy and breast cancer risk 10 years after the WHI.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Mammographic breast density as an intermediate phenotype for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Aromatase immunoreactivity is increased in mammographically dense regions of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Postmenopausal hormone therapy and change in mammographic density

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Hormone therapy, mammographic density, and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Breast cancer risk in postmenopausal women using estradiol-progestogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Transcriptional profiles of progestogen effects in the postmenopausal breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Pregnancy, progesterone and progestins in relation to breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Breast cancer risk in relation to the interval between menopause and starting hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2013.808563